Chelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Rd., London SW10 9NH, UK.
Hammersmith Private Hospital, Enhance Medical Group, The Triangle, 5-17 Hammersmith Grove, London W6 0LG, UK.
Medicina (Kaunas). 2024 Apr 29;60(5):743. doi: 10.3390/medicina60050743.
: The correction of breast hypertrophy and ptosis with implant placement has always posed a challenge for plastic surgeons. Various methods have been devised, yielding conflicting results. The purpose of this study is to describe our surgical technique of breast reduction with silicone implants, present the safety profile of the procedure, and report patient-reported outcomes. : A retrospective review was performed on our case series of cosmetic breast surgery performed by the senior author between October 2020 and November 2023. Only patients who had over 300 g of breast tissue removed were included. The surgery and demographic characteristics were recorded. Patients were asked to complete a questionnaire about satisfaction with their breasts pre-operatively and after the surgery. : Over 745 cases were performed, and 25 were included in the analysis. In total, 78.3% of the patients presented with a Grade 3 ptosis. The mean implant size was 352.39 cc (range 300-455 cc). The breast tissue removed ranged from 312 to 657 g. The mean follow-up was 14.17 months. Only one case required revision surgery after developing capsular contracture and a waterfall deformity. Patients reported a statistically significant improvement across all domains of the questionnaire ( < 0.001). : Breast reduction plus implants is a safe and effective alternative for patients with large ptotic breasts who wish to attain a full upper pole. It carries a similar risk profile to augmentation mastopexy and maintains its functional benefits in alleviating back, neck, and shoulder pain.
乳房肥大和下垂的矫正一直是整形外科医生面临的挑战。各种方法已经被设计出来,但结果却相互矛盾。本研究旨在描述我们使用硅胶植入物进行乳房缩小的手术技术,展示该手术的安全性,并报告患者报告的结果。
我们对 2020 年 10 月至 2023 年 11 月期间由资深作者进行的美容乳房手术的病例系列进行了回顾性研究。只有那些切除了超过 300 克乳房组织的患者才被纳入研究。记录了手术和人口统计学特征。患者被要求在术前和术后完成一份关于对乳房满意度的问卷。
在超过 745 例手术中,有 25 例被纳入分析。共有 78.3%的患者存在 3 级下垂。平均植入物大小为 352.39 立方厘米(范围 300-455 立方厘米)。切除的乳房组织范围为 312 至 657 克。平均随访时间为 14.17 个月。只有 1 例患者因发生包膜挛缩和瀑布畸形而需要再次手术。患者报告问卷的所有领域都有统计学意义上的显著改善(<0.001)。
乳房缩小加植入物是一种安全有效的替代方案,适用于希望获得丰满上极的大下垂乳房患者。它具有与隆胸乳房悬吊术相似的风险特征,并保持其在缓解背部、颈部和肩部疼痛方面的功能益处。
Aesthetic Plast Surg. 2004
Aesthetic Plast Surg. 2022-8
Ann Plast Surg. 2003-12
Aesthetic Plast Surg. 2019-5-7
Plast Reconstr Surg Glob Open. 2022-1-27
Aesthetic Plast Surg. 2019-2-6
Aesthetic Plast Surg. 2018-6
Plast Reconstr Surg Glob Open. 2016-12-27
Plast Reconstr Surg. 2015-10
Plast Reconstr Surg Glob Open. 2015-1-8
Plast Reconstr Surg. 2014-11
Plast Reconstr Surg Glob Open. 2014-1-6